Takeda Pharmaceutical Co Ltd
SWB:TKD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Takeda Pharmaceutical Co Ltd
SWB:TKD
|
JP |
|
Ypsomed Holding AG
F:OWX
|
CH |
|
Namura Shipbuilding Co Ltd
OTC:NMRSF
|
JP |
|
M
|
Murray & Roberts Holdings Ltd
JSE:MUR
|
ZA |
|
Planet Fitness Inc
NYSE:PLNT
|
US |
|
Clorox Co
NYSE:CLX
|
US |
|
E
|
EDP Energias de Portugal SA
F:EDP
|
PT |
|
A
|
Advance Auto Parts Inc
F:AWN
|
US |
|
Rexford Industrial Realty Inc
NYSE:REXR
|
US |
Wall St Price Targets
TKD Price Targets Summary
Takeda Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for TKD is 34.68 EUR with a low forecast of 28.57 EUR and a high forecast of 45.13 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TKD's stock price target?
Price Target
34.68
EUR
According to Wall Street analysts, the average 1-year price target for TKD is 34.68 EUR with a low forecast of 28.57 EUR and a high forecast of 45.13 EUR.
What is the Revenue forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 1%.
What is the Operating Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 2 years is -5%.
What is the Net Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
44%
Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 3 years is 44%.
